Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
J Perinatol ; 17(4): 262-5, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9280088

RESUMO

OBJECTIVE: The purpose of this study was to evaluate the impact of exogenous surfactant on the duration of extracorporeal membrane oxygenation needed to support neonates. STUDY DESIGN: Retrospective case review. RESULTS: The duration of extracorporeal membrane oxygenation decreased from 112 +/- 43.3 hours to 76 +/- 17.9 hours. There was no difference in duration of mechanical ventilation, duration of supplemental oxygen, incidence of chronic lung disease, or length of hospital stay. CONCLUSION: Surfactant administered soon after initiation of extracorporeal membrane oxygenation results in a significant reduction in the duration of extracorporeal support for neonates.


Assuntos
Oxigenação por Membrana Extracorpórea , Recém-Nascido/fisiologia , Surfactantes Pulmonares/uso terapêutico , Feminino , Humanos , Masculino , Estudos Retrospectivos , Fatores de Tempo
2.
J Perinatol ; 17(1): 3-9, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9069056

RESUMO

OBJECTIVE: The objective of this study was to evaluate the efficacy and safety of high-frequency jet ventilation in near-term and term neonates with persistent pulmonary hypertension. STUDY DESIGN: Subjects for this prospective, randomized, controlled comparison study were recruited from neonates treated in a level-three neonatal intensive care unit that accepts referrals for extracorporeal membrane oxygenation. RESULTS: In patients treated with high-frequency jet ventilation (n = 11) acute improvement in oxygenation (p = 0.008), ventilation (p < 0.001), and oxygen indices (p < or = 0.01) was demonstrated while stable peak and mean airway pressures were maintained. Control group patients receiving high-frequency positive pressure ventilation with a conventional ventilator required increasingly higher peak inspiratory pressures (p = 0.005) to maintain oxygenation, ventilation, and oxygen indices. There were no significant differences in survival without use of extracorporeal membrane oxygenation, nor were there differences in duration of oxygen therapy, ventilation, and hospitalization; need for extracorporeal membrane oxygenation; or incidence of chronic lung disease. CONCLUSIONS: High-frequency jet ventilation acutely improves oxygenation and ventilation without significantly increasing morbidity. Therefore high-frequency jet ventilation may be a useful adjunct for stabilization of the conditions of neonates with severe persistent pulmonary hypertension. Conclusions about the efficacy of high-frequency jet ventilation in improving survival without the need for extracorporeal membrane oxygenation await multicentered, collaborative investigations with large cohorts of patients.


Assuntos
Ventilação em Jatos de Alta Frequência , Hipertensão Pulmonar/terapia , Síndrome do Desconforto Respiratório do Recém-Nascido/terapia , Análise de Variância , Feminino , Idade Gestacional , Humanos , Hipertensão Pulmonar/complicações , Hipertensão Pulmonar/mortalidade , Recém-Nascido , Masculino , Respiração com Pressão Positiva , Estudos Prospectivos , Respiração Artificial , Síndrome do Desconforto Respiratório do Recém-Nascido/complicações , Síndrome do Desconforto Respiratório do Recém-Nascido/mortalidade , Testes de Função Respiratória , Taxa de Sobrevida , Resultado do Tratamento
3.
J Perinatol ; 16(3 Pt 1): 191-6, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8817428

RESUMO

The objective of this study was to assess the respiratory, neurologic, and developmental status at age 2 years of children treated with extracorporeal membrane oxygenation (ECMO) as neonates. The study population comprised patients treated at a tertiary care neonatal unit and included in a high-risk follow-up program. Eighty-five consecutive patients were treated with ECMO between June 1987 and October 1990, of which 64 (75%) survived. Forty-eight (73%) of the survivors underwent evaluation of growth and respiratory status, neurologic examination, and psychometric testing at ages 1 and 2 years. At age 2 years, 21% of study patients had at least one abnormal growth parameter (weight or length < 5%, head circumference < 2%). Twenty-one percent required respiratory medications and two children had tracheostomies. Six percent had significant abnormalities on neurologic examination. Twenty-five percent scored between 70 and 85 on the mental or psychomotor scales (or both) of the Bayley Scales of Infant Development or the Stanford-Binet, and 12% scored less than 70. Seventy-three percent of children who scored 70 to 85 on one or both subscales of the Bayley Scales of Infant Development or the Stanford-Binet at 2 years had normal scores at 1 year, as did 50% with scores less than 70. Spearman rank analysis suggested a relationship between congenital diaphragmatic hernia, neonatal electroencephalogram, and computed tomography of the head and developmental status at age 2 years (p < 0.05). We conclude that children treated with ECMO are at significant risk for abnormalities in growth and neurodevelopmental and respiratory status at age 2 years, which may not be evident at earlier assessments. This highlights the need for continued follow-up.


Assuntos
Sistema Nervoso Central/fisiologia , Desenvolvimento Infantil/fisiologia , Oxigenação por Membrana Extracorpórea , Fenômenos Fisiológicos Respiratórios , Pré-Escolar , Estudos de Avaliação como Assunto , Seguimentos , Humanos , Recém-Nascido , Prognóstico
4.
J Perinatol ; 13(5): 368-75, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8263621

RESUMO

Mortality risk indicators may be useful adjuncts to clinical judgment in considering the use of extraordinary and relatively high-risk treatments such as high-frequency ventilation, extracorporeal membrane oxygenation, and nitric oxide therapy. We retrospectively evaluated the reliability of published indications of high mortality, developed additional high-risk indicators, and determined the interval between the time when high-risk indicators were met and when death occurred in near-term and term neonates with respiratory failure. Patients were included in the analysis if they met the following criteria: > or = 35 weeks gestation, > or = 2 kg birth weight, < or = 7 days of age, and receiving a fraction of inspired oxygen of > or = 0.8 and mechanical ventilation. Patients were excluded if they had congenital heart disease, intracranial hemorrhage, untreatable bleeding diathesis, or lethal congenital anomaly. Fifteen patients in the 1980 to 1981 group and 41 patients in the 1985 to 1987 group met these criteria. We observed 100% mortality in our 1980 to 1981 patients who met previously published criteria predictive for > or = 80% mortality in near-term and term neonates with respiratory failure; however, mortality risk was 60% to 80% in the 1985 to 1987 group.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Insuficiência Respiratória/mortalidade , Idade Gestacional , Humanos , Recém-Nascido , Oxigênio/sangue , Insuficiência Respiratória/sangue , Insuficiência Respiratória/etiologia , Estudos Retrospectivos , Fatores de Risco , Fatores de Tempo
5.
Indiana Med ; 86(4): 318-24, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8366283

RESUMO

Patency of the ductus arteriosus is one of the more common problems of the neonate. Although the ductus arteriosus usually closes within the first days of life, persistent patency can complicate the clinical status of a newborn. The ductus arteriosus also may play a role in the pathophysiology of persistent pulmonary hypertension of the newborn and in some forms of congenital heart disease. Diagnosis of patent ductus arteriosus can be suspected clinically but should be verified by echocardiography before treatment. Accurate diagnosis, early intervention and proper treatment are necessary to decrease the immediate risks and minimize the potential for long-term complications.


Assuntos
Permeabilidade do Canal Arterial , Contraindicações , Permeabilidade do Canal Arterial/diagnóstico , Permeabilidade do Canal Arterial/fisiopatologia , Permeabilidade do Canal Arterial/terapia , Hemodinâmica , Humanos , Indometacina/uso terapêutico , Recém-Nascido
6.
Ann Surg ; 216(4): 454-60; discussion 460-2, 1992 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1417195

RESUMO

One hundred ten infants with congenital diaphragmatic hernia (CDH) developed life-threatening respiratory distress in the first 6 hours of life. Associated anomalies were present in 33%. Twenty-eight of 65 infants (43%) treated before 1987 (pre-extracorporeal membrane oxygenation [ECMO] era) survived after immediate CDH repair, and mechanical ventilation with or without pharmacologic support. Only two of 16 (12.5%) infants requiring a prosthetic diaphragmatic patch survived. Since 1987, 31 of 46 (67.4%) infants with birth weight, gestational age, and severity of illness similar to the pre-1987 group survived. All patients were immediately intubated and ventilated. Seven (four with lethal chromosomal anomalies) infants died before treatment, and 30 stabilized (partial pressure of carbon dioxide [PCO2] < 50; partial pressure of oxygen [PO2] > 100; pH > 7.3) and underwent delayed CDH repair at 5 to 72 hours. Fifteen did well on conventional support and survived. Fifteen infants deteriorated after operation: 11 were placed on ECMO with eight survivors, and four infants were not considered ECMO candidates. Nine babies failed to stabilize initially and were placed on ECMO before CDH repair (alveolar-arterial gradient > 600 and oxygenation index > 40), and seven survived. The overall survival rate was 80% at 3 months in this ECMO-treated group. Early mortality was due to inability to wean from ECMO (one), intracranial hemorrhage (one), liver injury (one), and pulmonary hypoplasia (one). Nine of 11 babies requiring a prosthetic patch in the post-1987 ECMO group survived (81.8%). There were three late post-ECMO deaths (3 to 18 months) of right heart failure (two) and sepsis (one). Symptomatic gastroesophageal reflux occurred in nine cases, six requiring a fundoplication in the bypass babies. Recurrent diaphragmatic hernia occurred in nine cases (five ECMO). The overall survival rate was significantly improved in the delayed repair/ECMO group (67% versus 43%; p < 0.05) and was most noticeable in infants requiring a prosthetic diaphragm (81.2% versus 12.5%; p < 0.005). These data indicate that early stabilization, delayed repair, and ECMO improve survival in high-risk CDH. Early deaths are related to pulmonary hypertension and can be reversed by ECMO.


Assuntos
Oxigenação por Membrana Extracorpórea , Hérnia Diafragmática/cirurgia , Feminino , Hérnia Diafragmática/complicações , Hérnia Diafragmática/mortalidade , Humanos , Recém-Nascido , Masculino , Insuficiência Respiratória/etiologia , Insuficiência Respiratória/terapia , Taxa de Sobrevida , Fatores de Tempo
7.
J Perinatol ; 12(1): 21-4, 1992 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1560286

RESUMO

Pulmonary hypoplasia in the neonate is frequently fatal. This article reports two neonates with a clinical diagnosis of pulmonary hypoplasia complicated by persistent pulmonary hypertension (PPHN). Though both infants were progressively worsening while receiving conventional mechanical ventilatory support, they survived when treated with high-frequency jet ventilation.


Assuntos
Ventilação em Jatos de Alta Frequência , Síndrome da Persistência do Padrão de Circulação Fetal/terapia , Humanos , Recém-Nascido , Pulmão/diagnóstico por imagem , Pulmão/patologia , Masculino , Síndrome da Persistência do Padrão de Circulação Fetal/patologia , Troca Gasosa Pulmonar/fisiologia , Radiografia
8.
J Pediatr Surg ; 27(1): 98-100, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1552455

RESUMO

A case is presented of acquired obliterative mainstem bronchial obstruction with total ipsilateral lung atelectasis and contralateral lung hyperexpansion. The condition failed to improve after a suitable trial of positive airway pressure and medical management. Penetration of the obstructing lesion bia bronchotomy and a distal retrograde approach successfully opened the airway and the patient has been symptom-free for more than 9 months. This unique approach may be useful in other selected patients with similar acquired lesions.


Assuntos
Obstrução das Vias Respiratórias/cirurgia , Brônquios/cirurgia , Broncopatias/cirurgia , Granuloma de Corpo Estranho/cirurgia , Obstrução das Vias Respiratórias/diagnóstico , Obstrução das Vias Respiratórias/etiologia , Broncopatias/diagnóstico , Broncopatias/etiologia , Broncoscopia , Dilatação , Feminino , Granuloma de Corpo Estranho/diagnóstico , Granuloma de Corpo Estranho/etiologia , Humanos , Recém-Nascido , Intubação Intratraqueal/efeitos adversos , Respiração com Pressão Positiva
9.
Indiana Med ; 83(8): 578-80, 1990 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2212589

RESUMO

In this article, we review the process of adoption in Indiana. Comments about the legal process, the right to know issue and the process of adoption from the viewpoint of the potential adoptive parents are discussed.


Assuntos
Adoção/legislação & jurisprudência , Indiana
10.
Am J Clin Pathol ; 93(2): 263-6, 1990 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2301287

RESUMO

Several investigators have enumerated cellular populations in neonatal cord blood with variable results. In this study, the authors established reference ranges for lymphocyte subsets in cord blood from healthy newborns using a whole blood lysis technique on the Coulter Immunoprep Epics Leukocyte Preparation System (Coulter Immunology, Hialeah, FL). All analyses were performed on a flow cytometer by gating on forward angle versus 90 degrees light scatter. Lymphocytes demonstrated all surface markers examined, including T4, T8, T3, T11, B1, NKH-1, I3, and 4B4; 2H4 suppressor inducer lymphocytes were prominent in neonatal blood. The authors think this standardized system may be suitable for use in neonatal and pediatric patients because it quickly processes small aliquots of whole blood with minimal sample manipulation.


Assuntos
Sangue Fetal , Linfócitos/citologia , Citometria de Fluxo , Humanos , Recém-Nascido , Contagem de Leucócitos , Valores de Referência
12.
J Perinatol ; 9(2): 159-61, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2661761

RESUMO

A term newborn with Candida albicans infection of the lungs and blood is described. Although no maternal risk factors were identified, this patient's rapid clinical deterioration and postmortem findings suggest congenital infection. Related cases in the literature are reviewed. This case suggests that a diagnosis of fungal pneumonia should be considered in any infant presenting with severe respiratory distress.


Assuntos
Candidíase/congênito , Pneumopatias Fúngicas/congênito , Pneumonia/congênito , Adulto , Candidíase/sangue , Feminino , Humanos , Recém-Nascido , Gravidez , Síndrome do Desconforto Respiratório do Recém-Nascido/etiologia
16.
Immunol Lett ; 19(1): 1-6, 1988 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3192277

RESUMO

Varying culture medium oxygen tension from one-half to twice the normal concentration did not alter adult or cord blood monocyte-derived macrophage secretion of lysozyme or total protein. Lowering oxygen tension did result in significant increases in fibronectin concentration in both adult and cord blood macrophage culture supernatants. Dexamethasone (10(-7) M) completely blocked adult macrophage but had no effect on cord blood macrophage fibronectin release in response to lowering oxygen tension. These results indicate that human macrophages selectively regulate fibronectin production in response to changes in oxygen tension in vitro.


Assuntos
Fibronectinas/biossíntese , Macrófagos/metabolismo , Oxigênio/metabolismo , Adulto , Proteínas Sanguíneas/biossíntese , Dexametasona/farmacologia , Sangue Fetal/citologia , Sangue Fetal/metabolismo , Fibronectinas/sangue , Humanos , Técnicas In Vitro , Recém-Nascido , Macrófagos/efeitos dos fármacos , Muramidase/biossíntese , Cicatrização
18.
Pediatr Res ; 23(3): 245-8, 1988 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-2832815

RESUMO

Pharmacologic serum levels of vitamin E administered to low birth weight infants predispose them to infectious complications. We studied in vitro the effect of vitamin E, its vehicle and buffer (Krebs Ringers phosphate glucose) on the ability of human polymorphonuclear leukocytes (PMN) to produce superoxide anion, an oxygen radical important for bacterial killing. We found that superoxide anion production after a 5-min exposure to phorbol myristate acetate was significantly decreased in vitamin E-treated PMN (76 +/- 15 nM/10(7) PMN) compared to vehicle-treated PMN (289 +/- 109 nM/10(7) PMN). We also found that significantly decreased superoxide anion production was associated with 5.0 and 10.0 mg/dl but not with 3.5 mg/dl vitamin E. Our results support the hypothesis that pharmacologic concentrations of vitamin E depress PMN oxidative activity.


Assuntos
Neutrófilos/efeitos dos fármacos , Superóxidos/antagonistas & inibidores , Vitamina E/farmacologia , Adulto , Relação Dose-Resposta a Droga , Humanos , Técnicas In Vitro , Neutrófilos/metabolismo , Superóxidos/biossíntese
19.
Am J Perinatol ; 4(2): 81-5, 1987 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3551977

RESUMO

Tracheobronchomegaly is rarely reported in neonates. We present five cases of tracheobronchomegaly occurring in neonates receiving intensive ventilatory and oxygen support. Barotrauma is speculated to be the primary pathophysiologic factor in these cases.


Assuntos
Doenças do Prematuro/terapia , Doenças da Traqueia/terapia , Traqueobroncomegalia/terapia , Doenças em Gêmeos , Feminino , Humanos , Recém-Nascido , Doenças do Prematuro/fisiopatologia , Masculino , Oxigenoterapia , Respiração com Pressão Positiva , Traqueobroncomegalia/fisiopatologia
20.
J Perinatol ; 7(4): 292-5, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3333164

RESUMO

Bacterial endocarditis in the neonate is rare and fatal in the majority of reported cases. This article reports two neonates who survived bacterial endocarditis. One patient was infected with group B beta-hemolytic streptococcus (GBBS) while the second grew Streptococcus saluvarius from the blood.


Assuntos
Endocardite Bacteriana , Valva Pulmonar , Infecções Estreptocócicas , Ampicilina/uso terapêutico , Ecocardiografia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/etiologia , Feminino , Gentamicinas/uso terapêutico , Humanos , Recém-Nascido , Masculino , Artéria Pulmonar/patologia , Valva Pulmonar/patologia , Infecções Estreptocócicas/diagnóstico , Infecções Estreptocócicas/tratamento farmacológico , Streptococcus agalactiae
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA